Infarct-related cardiogenic shock - Diagnosis, monitoring and therapy;Infarktbedingter kardiogener schock - Diagnose, monitoring und therapie

Intensivmedizin und Notfallmedizin

Volumn 46, Issue 3, 2009, Pages 132-145

  Buerke, Michael ^a   Russ, Martin ^a   Prondzinsky, Roland ^a   Werdan, Karl ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Cardiogenic shock; Drug therapy; Mechanical support; Revascularization

Indexed keywords

EID: 67649792159     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00390-009-0037-0     Document Type: Article

References (86)

1. A Babaev PD Frederick DJ Pasta N Every T Sichrovsky JS Hochman 2005 Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Jama 294 448
2. M Okuda 2006 A multidisciplinary overview of cardiogenic shock. Shock 25 557
3. HP Schuster FP Schuster P Ritschel S Wilts KF Bodmann 1997 The ability of the Simplified Acute Physiology Score (SAPS II) to predict outcome in coronary care patients. Intensive Care Med 23 1056
4. HA Adams G Baumann A Gansslen 2001 Definitionen der Schockformen AINS 36 2 140
5. D Hasdai EJ Topol RM Califf PB Berger DR Holmes 2000 Cardiogenic shock complicating acute coronary syndromes Lancet 356 749
6. Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS (2000) The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 36 (Suppl A):1071-6
7. SM Hollenberg 2001 Cardiogenic shock Crit Care Clin 17 391
8. SM Hollenberg CJ Kavinsky JE Parrillo 1999 Cardiogenic shock Ann Intern Med 131 47
9. R Califf J Bengtson 1994 Cardiogenic shock N Engl J Med 330 1724
10. JS Hochman LA Sleeper JG Webb 1999 Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 341 625
11. MG Lindholm L Kober S Boesgaard C Torp-Pedersen J Aldershvile 2003 Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development. Eur Heart J 24 258
12. JS Hochman CE Buller LA Sleeper 2000 Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36 1063
13. JS Hochman LA Sleeper HD White 2001 One-year survival following early revascularization for cardiogenic shock. Jama 285 190
14. JS Hochman LA Sleeper JG Webb 2006 Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial Infarction. Jama 295 2511
15. JG Webb AM Lowe TA Sanborn 2003 Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 42 1380
16. U Zeymer A Vogt R Zahn 2004 Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 25 322
17. HD White SF Assmann TA Sanborn 2005 Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 112 1992
18. C Patrono 1994 Aspirin as an antiplatelet drug. N Engl J Med 330 1287
19. S Roux S Christeller E Ludin 1992 Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis. J Am Coll Cardiol 19 671
20. MJ Quinn DJ Fitzgerald 1999 Ticlopidine and clopidogrel. Circulation 100 1667
21. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial I. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. N Engl J Med (2001) 345:494-502
22. SR Steinhubl PB Berger JT Mann 2002 Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Jama 288 2411
23. MS Sabatine CP Cannon CM Gibson 2005 Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation. N Engl J Med 352 1179
24. ZM Chen HC Pan YP Chen 2005 Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 1622
25. D Antoniucci A Rodriguez A Hempel 2003 A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol 42 1879
26. G Montalescot P Barragan O Wittenberg 2001 Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction. N Engl J Med 344 1895
27. FJ Neumann R Blasini C Schmitt 1998 Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 98 2695
28. GW Stone CL Grines DA Cox 2002 Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction. N Engl J Med 346 957
29. D Antoniucci R Valenti A Migliorini 2002 Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 90 353
30. AW Chan DP Chew DL Bhatt DJ Moliterno EJ Topol SG Ellis 2002 Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 89 132
31. S Giri J Mitchel RR Azar 2002 Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 89 126
32. Reid P, Gu X, Jamal H (2003) Abciximab treatment for acute myocardial infarction: mortality in patients with cardiogenic shock. Eur Heart J 25 (Suppl):Abstract 255
33. U Zeymer U Tebbe M Weber 2003 Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial. J Invasive Cardiol 15 385
34. D Hasdai RA Harrington JS Hochman 2000 Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 36 685
35. CR Narins WB Hillegass CL Nelson 1996 Relation Between Activated Clotting Time During Angioplasty and Abrupt Closure. Circulation 93 667
36. K-L Neuhaus GP Molhoek U Zeymer 1999 Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction : Results of the HIT-4 trial. J Am Coll Cardiol 34 966
37. The Global Use of Strategies to Open Occluded Coronary Arteries II. A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes. N Engl J Med (1996) 335:775-782
38. The Hirulog and Early Reperfusion or Occlusion -2 Trial. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. The Lancet (2001) 358:1855-1863
39. PK Coussement JP Bassand 2001 A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study. Eur Heart J 22 1716
40. WE Boden 2002 Is it time to reassess the optimal timing of coronary artery bypass graft surgery following acute myocardial infarction? Am J Cardiol 90 35
41. JS Hochman LA Sleeper E Godfrey 1999 SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. Am Heart J 137 313
42. SG Williams DJ Wright LB Tan 2000 Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice. Heart 83 621
43. JS Hochman 2003 Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107 2998
44. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology, Van de Werf F, Ardissino D, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2003) 24:28-66 (Pubitemid 36109547)
45. EM Antman DT Anbe PW Armstrong 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 44 E1
46. GW Stone EM Ohman MF Miller 2003 Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: The benchmark registry. J Am Coll Cardiol 41 1940
47. Prondzinsky R, Lemm H, Swyter M, et al (2006) A Prospective, Randomized Evaluation of Intraaortic Balloon Counterpulsation for the Prevention of Multiorgan-Dysfunction and -Failure in Patients with Acute Myocardial Infarction complicated by Cardiogenic Shock. Circulation Supplement 114:II-555 (2668)
48. M Cohen P Urban JT Christenson 2003 Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark(R) Registry. Eur Heart J 24 1763
49. RD Anderson EM Ohman DR Holmes 1997 Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 30 708
50. EW Chen JG Canto LS Parsons 2003 Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation 108 951
51. HV Barron NR Every LS Parsons 2001 The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2. Am Heart J 141 933
52. H Hausmann EV Potapov A Koster 2002 Prognosis After the Implantation of an Intra-Aortic Balloon Pump in Cardiac Surgery Calculated With a New Score. Circulation 106 203I
53. N Doll B Kiaii M Borger 2004 Five-Year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. The Ann Thorac Surg 77 151
54. Sibbald WJ, Keenan SP (1997) Show me the evidence: a critical appraisal of the Pulmonary Artery Catheter Consensus Conference and other musings on how critical care practitioners need to improve the way we conduct business. Crit Care Med 25:2060-2063 (Pubitemid 28007248)
55. HS Mueller K Chatterjee KB Davis 1998 ACC expert consensus document. Present use of bedside right heart catheterization in patients with cardiac disease. American College of Cardiology. J Am Coll Cardiol 32 840
56. C Binanay RM Califf V Hasselblad 2005 Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. Jama 294 1625
57. Müller-Werdan U, Buerke M, Christoph A, et al (2006) Septische Kardiomyopathie. Intensivmed 43:486-497 (Pubitemid 44408355)
58. RS Friese S Shafi LM Gentilello 2006 Pulmonary artery catheter use is associated with reduced mortality in severely injured patients: a National Trauma Data Bank analysis of 53,312 patients. Crit Care Med 34 1597
59. O Gödje C Thiel P Lamm 1999 Less invasive, continuous hemodynamic monitoring during minimally invasive coronary surgery Ann Thorac Surg 68 1540
60. G Cotter Y Moshkovitz E Kaluski 2003 The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 5 443
61. R Fincke JS Hochman AM Lowe 2004 Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry. 44 340
62. DD Mendoza HA Cooper JA Panza 2007 Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 153 366
63. L De Luca WS Colucci MS Nieminen BM Massie M Gheorghiade 2006 Evidence-based use of levosimendan in different clinical settings. Eur Heart J 27 1908
64. CA Innes AJ Wagstaff 2003 Levosimendan: a review of its use in the management of acute decompensated heart failure. Drugs 63 2651
65. Jr R Rokyta V Pechman 2006 The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock. Neuro Endocrinol Lett 27 121
66. Karth Delle A Buberl A Geppert 2003 Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 47 1251
67. MJ Garcia-Gonzalez A Dominguez-Rodriguez JJ Ferrer-Hita P Abreu-Gonzalez MB Munoz 2006 Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics. Eur J Heart Fail 8 723
68. A Christoph R Prondzinsky M Russ 2008 Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction. Acute Card Care 10 49
69. MA Russ R Prondzinsky A Christoph 2007 Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 35 2732
70. JT Fuhrmann A Schmeisser MR Schulze 2008 Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med 36 2257
71. S Jolly G Newton E Horlick 2005 Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 96 1617
72. A Geppert A Dorninger G Delle-Karth G Zorn G Heinz K Huber 2006 Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med 34 2035
73. G Cotter PB Berger 2006 Cardiogenic shock - Beyond the large infarction. Crit Care Med 34 2234
74. S Kohsaka V Menon AM Lowe 2005 Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 165 1643
75. G Cotter E Kaluski O Milo 2003 LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur Heart J 24 1287
76. The Triumph-Investigators. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. Jama (2007) 297:1657-66
77. H Schiffl SM Lang R Fischer 2002 Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346 305
78. Angstwurm M, Gärtner R (2005) Endokrine Störungen und Spurenelementdefizienzen. In: Sepsis und MODS (Hrsg: Werdan K, Schuster H-P, Müller-Werdan U), Springer Medizin Verlag Heidelberg, 4. Auflage:473-483
79. K Reinhart FM Brunkhorst HG Bone 2006 Diagnose und Therapie der Sepsis : S2-Leitlinien der Deutschen Sepsis-Gesellschaft e.V. (DSG) und der Deutschen Interdisziplinaren Vereinigung fur Intensiv- und Notfallmedizin (DIVI). Internist 47 356
80. E Kilger F Weis J Briegel 2003 Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31 1068
81. P Devos R Chiolero G Berghe JC Preiser 2006 Glucose, insulin and myocardial ischaemia. Curr Opin Clin Nutr Metab Care 9 131
82. G Berghe 2004 How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114 1187
83. G Berghe P Wouters F Weekers 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345 1359
84. G Berghe A Wilmer G Hermans 2006 Intensive insulin therapy in the medical ICU. N Engl J Med 354 449
85. FM Brunkhorst K Werdan 2006 Intensivmedizin - Nach den positiven Studien kommen die Fragen. Dtsch Med Wochenschr 131 1441
86. H Schmidt U Muller-Werdan T Hoffmann 2005 Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med 33 1994